Cobalamin conjugates for anti-tumor therapy

Details for Australian Patent Application No. 2004272105 (hide)

Owner Inflabloc Pharmaceuticals, Inc.

Inventors Li, Weiping; West, Frederick G.; Weinshenker, Ned M.; Araneo, Barbara A.

Agent FB Rice

Pub. Number AU-B-2004272105

PCT Pub. Number WO2005/025512

Priority 10/659,501 10.09.03 US

Filing date 10 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 10 March 2011

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/714 (2006.01)

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

2 November 2006 Assignment before Grant

  Manticore Pharmaceuticals, Inc. The application has been assigned to Inflabloc Pharmaceuticals, Inc.

26 July 2007 PCT application entered the National Phase

  PCT publication WO2005/025512 Priority application(s): WO2005/025512

10 March 2011 Application Accepted

  Published as AU-B-2004272105

14 July 2011 Assignment before Grant

  Inflabloc Pharmaceuticals, Inc. The application has been assigned to Osiris Therapeutics, Inc. 2005

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272107-Compounds that modulate neuronal growth and their uses

2004272104-Fused ring heterocycles as potassium channel modulators